Patent · US Active

Treatment of cancers with immunostimulatory HIV TAT derivative polypeptides

US8530431B2 · kind B2 · utility

4Cited by
1References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 23, 2010
Grant dateSep 10, 2013
Priority date—
Expiry dateApr 21, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2740/16322
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are methods of treating cancer by administering a modified Human Immunodeficiency Virus (HIV) trans-activator of transcription (Tat) polypeptide with increased immunostimulatory properties relative to the non-modified Tat polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.